GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Knight Therapeutics Inc (FRA:04K) » Definitions » Float Percentage Of Total Shares Outstanding

Knight Therapeutics (FRA:04K) Float Percentage Of Total Shares Outstanding : 0.00% (As of Jun. 10, 2024)


View and export this data going back to 2014. Start your Free Trial

What is Knight Therapeutics Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Knight Therapeutics's float shares is 0.00 Mil. Knight Therapeutics's total shares outstanding is 101.38 Mil. Knight Therapeutics's float percentage of total shares outstanding is 0.00%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Knight Therapeutics's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Knight Therapeutics's Institutional Ownership is 12.42%.

Knight Therapeutics Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Knight Therapeutics's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=0.00/101.38
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Knight Therapeutics (FRA:04K) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Knight Therapeutics Inc (FRA:04K) » Definitions » Float Percentage Of Total Shares Outstanding
Comparable Companies
XCNQ:CL TSX:WEED NEOE:GLAS.A.U TSX:DHT.U TSX:TSND XCNQ:AAWH.U TSX:ACB XCNQ:EPIC XCNQ:IAN NEOE:CBST ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
KHTRF:USA GUD:Canada
Address
3400 De Maisonneuve West, Suite 1055, Montreal, QC, CAN, H3Z 3B8
Website
https://www.gud-knight.com
Knight Therapeutics Inc is a specialty and generic drug manufacturing company. The company's principal business activity is focused on developing, acquiring, in-licensing, out-licensing, marketing, and distributing pharmaceutical products, consumer health products, and medical devices in Canada, Ltin America and select international markets. Knight finances other life sciences companies across the globe in order to generate interest income, strengthen relationships in the life sciences industry, and to secure product distribution rights.

Knight Therapeutics (FRA:04K) Headlines

No Headlines